Assessment of efficacy and impact on work productivity and attendance after a mandatory switch to generic second-generation antihistamines: results of a patient survey in Norway

BACKGROUND: In 2006, the Norwegian Medicines Agency mandated a switch from desloratadine, ebastine, or fexofenadine to cetirizine or loratadine in patients with allergic rhinitis (AR) or chronic urticaria (CU). In an online survey, patients whose medication was switched assessed the impact on effica...

Descripción completa

Detalles Bibliográficos
Autores principales: Thorn, Fredrik, Celius, Halvor, Ødegård, Tone, Mandla, Randeep, Hexeberg, Erik
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3053265/
https://www.ncbi.nlm.nih.gov/pubmed/21356091
http://dx.doi.org/10.1186/1476-7961-9-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3053265/
https://www.ncbi.nlm.nih.gov/pubmed/21356091
http://dx.doi.org/10.1186/1476-7961-9-5

Ejemplares similares